Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636)

被引:15
作者
Zachariassen, Zack G. [1 ]
Karlshoj, Stefanie [2 ]
Haug, Bengt Erik [3 ,4 ]
Rosenkilde, Mette M. [2 ]
Vabeno, Jon [1 ]
机构
[1] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, NO-9037 Tromso, Norway
[2] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth & Med Sci,Panum Inst, DK-2200 Copenhagen, Denmark
[3] Univ Bergen, Dept Chem, NO-5007 Bergen, Norway
[4] Univ Bergen, Ctr Pharm, NO-5007 Bergen, Norway
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; BICYCLAM NONPEPTIDE ANTAGONISTS; LIGAND-BINDING SITES; CYCLOPENTAPEPTIDE ANTAGONISTS; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; HIV-1; ENTRY; POTENT; MECHANISM; INHIBITION;
D O I
10.1021/acs.jmedchem.5b00987
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (1). A limited SAR study based on the three functionalities of 1 was first conducted, followed by site-directed mutagenesis studies. The receptor mapping showed that both the potency and affinity of 1 were dependent on the transmembrane residues His(113), Asp(171), Asp(262), and His(281) and also suggested the involvement of Tyr(45) and Gln(200). (potency) and Tyr(116) and Glu(288) (affinity). Molecular docking of 1 to an X-ray structure of CXCR4 showed that the L-Arg guanidino group of 1 forms polar interactions with His(113) and Asp(171) and the (pyridin-2-ylmethyl)amino moiety is anchored by Asp(262) and His(281), whereas the naphthalene ring is tightly packed in a hydrophobic subpocket formed by the aromatic side chains of Trp(94), Tyr(45), and Tyr(116). The detailed picture of ligand-receptor interactions provided here will assist in structure-based design and further development of small-molecule peptidomimetic CXCR4 antagonists.
引用
收藏
页码:8141 / 8153
页数:13
相关论文
共 68 条
[1]  
[Anonymous], ADV ANTIV D
[2]   CRYSTAL-STRUCTURE OF INTERLEUKIN-8 - SYMBIOSIS OF NMR AND CRYSTALLOGRAPHY [J].
BALDWIN, ET ;
WEBER, IT ;
STCHARLES, R ;
XUAN, JC ;
APPELLA, E ;
YAMADA, M ;
MATSUSHIMA, K ;
EDWARDS, BFP ;
CLORE, GM ;
GRONENBORN, AM ;
WLODAWER, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :502-506
[3]  
Ballesteros J. A., 1995, METH NEUROSCI, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]
[4]   A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains [J].
Berson, JF ;
Long, D ;
Doranz, BJ ;
Rucker, J ;
Jirik, FR ;
Doms, RW .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6288-6295
[5]   The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry [J].
Bleul, CC ;
Farzan, M ;
Choe, H ;
Parolin, C ;
ClarkLewis, I ;
Sodroski, J ;
Springer, TA .
NATURE, 1996, 382 (6594) :829-833
[6]   Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities [J].
Brelot, A ;
Heveker, N ;
Montes, M ;
Alizon, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23736-23744
[7]   Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses [J].
Brelot, A ;
Heveker, N ;
Adema, K ;
Hosie, MJ ;
Willett, B ;
Alizon, M .
JOURNAL OF VIROLOGY, 1999, 73 (04) :2576-2586
[8]   Regulation of CXCR4 signaling [J].
Busillo, John M. ;
Benovic, Jeffrey L. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (04) :952-963
[9]   Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4) [J].
Choi, Won-Tak ;
Duggineni, Srinivas ;
Xu, Yan ;
Huang, Ziwei ;
An, Jing .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (03) :977-994
[10]   Unique ligand binding sites on CXCR4 probed by a chemical biology approach: Implications for the design of selective human immunodeficiency virus type 1 inhibitors [J].
Choi, WT ;
Tian, SM ;
Dong, CZ ;
Kumar, S ;
Liu, DX ;
Madani, N ;
An, J ;
Sodroski, JG ;
Huang, ZW .
JOURNAL OF VIROLOGY, 2005, 79 (24) :15398-15404